Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Publikováno v:
BMC Cancer
Background In the past decades, mortality of female gender related cancers declined in Switzerland and other developed countries. Differences in the decrease and in spatial patterns within Switzerland have been reported according to urbanisation and
Autor:
Riikka Nurminen, Johanna Schleutker, Heli Nevanlinna, Liisa M. Pelttari, Lauri A. Aaltonen, Alexandra E. Gylfe
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 552 (2012)
BMC Cancer
BMC Cancer
Background Rare, heterozygous germline mutations in the RAD51C gene have been found in breast and ovarian cancer families. In the Finnish population, we have identified two founder mutations in RAD51C that increase the risk of ovarian cancer but not
Autor:
Elton Rexhepaj, Darran P. O'Connor, Donal J. Brennan, Mathias Uhlén, Fredrik Pontén, Michael E. Foley, Jenny Brändstedt, Colm O'Herlihy, Karin Jirström, William M. Gallagher
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 125 (2010)
BMC Cancer; 10 (2010)
BMC Cancer, Vol 10, Iss 1, p 125 (2010)
BMC Cancer; 10 (2010)
Background Our group previously reported that tumour-specific expression of the rate-limiting enzyme in the mevalonate pathway, 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMG-CoAR) is associated with more favourable tumour parameters and a goo
Autor:
Mathias Krockenberger, Michaela Kapp, Arnd Honig, Lorenz Rieger, Matthias Eck, Ulrike Kämmerer, Johannes Dietl
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 199 (2006)
BMC Cancer
BMC Cancer
Background Tartrate-resistant acid phosphatase (TRAP) is a metalloprotein enzyme that belongs to the acid phosphatases and is known to be expressed by osteoclasts. It has already been investigated as a marker of bone metastases in cancer patients. In
Autor:
Carl Blomqvist, Pia Vahteristo, Heli Nevanlinna, Anitta Tamminen, Hannaleena Eerola, Kristiina Yliannala
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 19 (2006)
BMC Cancer
BMC Cancer
Background BACH1 (BRCA1-associated C-terminal helicase 1; also known as BRCA1-interacting protein 1, BRIP1) is a helicase protein that interacts in vivo with BRCA1, the protein product of one of the major genes for hereditary predisposition to breast
Autor:
Chen Shochat, Muhmud Badrriyah, Luna Kadouri, Sigal Korem, Gila Glusman, Israela Lerer, Dani Bercovich, Dvorah Abeliovich, Tamar Hamburger, Aviram Nissan, Tamar Peretz, Michal Sagi, Arava Elimelech, Nahil Abu-Halaf
Publikováno v:
BMC Cancer
BMC Cancer, Vol 7, Iss 1, p 14 (2007)
BMC Cancer, Vol 7, Iss 1, p 14 (2007)
Background The incidence of breast cancer (BC) in Arab women is lower compared to the incidence in the Jewish population in Israel; still, it is the most common malignancy among Arab women. There is a steep rise in breast cancer incidence in the Arab